Verge Genomics

Address
131 Oyster Point Boulevard Suite 300

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
8
research centres
public
5
countries
person_search
9
investigators

Specializations

Amyotrophic Lateral Sclerosis

Clinical research is centered on Amyotrophic Lateral Sclerosis, including both sporadic and familial forms of the disease, with a focus on treatment development for this progressive motor neuron disease.

  • Neurodegeneration
  • Motor neuron dysfunction
  • Familial ALS
  • Sporadic ALS

Research activity is concentrated in neurology and neurodegenerative disease, reflecting interest in therapies for disorders marked by progressive loss of motor function.

Neuromuscular Disorders

The sponsor’s trial portfolio also aligns with neuromuscular disease research, particularly conditions involving weakening of voluntary muscle control and impairment of movement.

  • Muscle weakness
  • Movement impairment
  • Progressive paralysis

This area highlights therapeutic interest in diseases where preserving neuromuscular function is central to clinical care.

Genetic and Sporadic Disease Forms

Research spans both genetic and non-inherited presentations of ALS, indicating attention to disease biology across different clinical subtypes.

  • Familial disease mechanisms
  • Sporadic disease mechanisms
  • Inherited neurodegeneration

This focus places molecular neuroscience and genetic medicine within the sponsor’s therapeutic interests.

Progressive Neurological Decline

The funded research is relevant to disorders characterized by gradual worsening of neurological function, including loss of strength, mobility, and respiratory-related impairment seen in advanced ALS.

  • Functional decline
  • Respiratory involvement
  • Advanced neurological impairment

These areas reflect sustained interest in central nervous system degeneration and the clinical burden of progressive neurodegenerative disorders.

Sponsored Trials

Trial Name Country Status
Phase 1b Open-Label Study of VRG50635 in Sporadic and Familial Amyotrophic Lateral Sclerosis Patients with Long-Term TreatmentBelgium BelgiumFinland FinlandSpain SpainSweden SwedenThe Netherlands The NetherlandsNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 8 sites collaborated multiple times

This sponsor has worked with 8 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

8 centres
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment1165
Katholieke Universiteit te Leuven
Address
Herestraat 49, 3000 Leuven
Learn morearrow_forward
location_city
assignment6
Meilahti Hospital
Address
P. O. Box 340, 00029 Helsinki
Learn morearrow_forward
location_city
assignment178
Pirkanmaan hyvinvointialue
Address
Elamanaukio 2, 33520 Tampere
Learn morearrow_forward
location_city
assignment4
Studieenheten Akademiskt Specialistcentrum
Address
Olivecronas väg 15, 113 61 Stockholm
Learn morearrow_forward
location_city
assignment206
Turku University Hospital
Address
Kiinamyllynkatu 4-8, 20520 Turku
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Verge Genomics.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.